Key statistics
As of last trade, NuCana PLC (N04:BER) traded at 2.92, 36.45% above the 52 week low of 2.14 set on Sep 10, 2024.
52-week range
Open | 2.88 |
---|---|
High | 3.00 |
Low | 2.88 |
Bid | 2.74 |
Offer | 3.10 |
Previous close | 2.96 |
Average volume | 3.54k |
---|---|
Shares outstanding | 90.66k |
Free float | 67.99k |
P/E (TTM) | -- |
Market cap | 7.29m USD |
EPS (TTM) | -234.80 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 12:05 BST.
More ▼
Announcements
- NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
- NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
- NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
- NuCana to Present at the Jefferies Global Healthcare Conference
- NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
- NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
- NuCana Announces Completion of ADS Ratio Change
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
- NuCana Announces Plan to Implement ADS Ratio Change
More ▼